摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

pyrazole-4-carbohydrazide | 87551-45-9

中文名称
——
中文别名
——
英文名称
pyrazole-4-carbohydrazide
英文别名
1H-pyrazole-4-carbohydrazide
pyrazole-4-carbohydrazide化学式
CAS
87551-45-9
化学式
C4H6N4O
mdl
MFCD12139713
分子量
126.118
InChiKey
NRSROFSJAIJRAN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    83.8
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Narrow SAR in odorant sensing Orco receptor agonists
    摘要:
    The systematic exploration of a series of triazole-based agonists of the cation channel insect odorant receptor is reported. The structure-activity relationships of independent sections of the molecules are examined. Very small changes to the compound structure were found to exert a large impact on compound activity. Optimal substitutions were combined using a 'mix-and-match' strategy to produce best-in-class compounds that are capable of potently agonizing odorant receptor activity and may form the basis for the identification of a new mode of insect behavior modification. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2014.04.081
  • 作为产物:
    描述:
    1H-吡唑-4-甲酸N,N'-羰基二咪唑 作用下, 以 四氢呋喃 为溶剂, 反应 18.0h, 生成 pyrazole-4-carbohydrazide
    参考文献:
    名称:
    人 NAD+ 依赖性 15-羟基前列腺素脱氢酶抑制剂的构效关系研究和生物学表征
    摘要:
    对鉴定为人类 NAD +依赖性 15-羟基前列腺素脱氢酶 (HPGD, 15-PGDH)抑制剂的两种化学型进行了构效关系 (SAR) 研究。来自两个系列的顶级化合物均显示出有效的抑制作用 (IC 50 <50 nM),对 HPGD 表现出出色的选择性,并在 A549 肺癌和 LNCaP 前列腺癌细胞中有效诱导 PGE 2产生。
    DOI:
    10.1016/j.bmcl.2013.11.081
点击查看最新优质反应信息

文献信息

  • [EN] [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES<br/>[FR] [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES
    申请人:BAYER AG
    公开号:WO2021028382A1
    公开(公告)日:2021-02-18
    The present invention covers [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds of general formula (I) in which R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of cancer or conditions with dysregulated immune responses or other disorders associated with aberrant AHR signaling, as a sole agent or in combination with other active ingredients.
    本发明涵盖了通式(I)中R1、R2、R3、R4、R5、R6、R7和R8如所定义的[1,2,4]三唑并[1,5-c]喹唑啉-5-胺化合物,以及制备所述化合物的方法,用于制备所述化合物的有用中间体化合物,包含所述化合物的药物组合物和组合物,以及利用所述化合物制造用于治疗或预防疾病的药物组合物,特别是癌症或与异常AHR信号传导相关的疾病,或与失调免疫反应或其他与异常AHR信号传导相关的疾病有关的情况,作为唯一药剂或与其他活性成分组合使用。
  • An advanced and applicable heat-resistant explosive through controllable regiochemical modulation
    作者:Tingou Yan、Hongwei Yang、Chen Yang、Zhenxin Yi、Shunguan Zhu、Guangbin Cheng
    DOI:10.1039/d0ta09158h
    日期:——
    for the thermostability of energetic materials have risen in the deep mining and aerospace industries, the research on heat-resistant explosives with remarkable thermal stability as well as high energy has always been a tough challenge. Here we present the synthesis and properties of an advanced heat-resistant explosive 5,5′-bis(3,5-dinitro-1H-pyrazol-4-yl)-1H,1′H-3,3′-bi(1,2,4-triazole) (BDBT-2). This
    由于深层采矿和航空工业对高能材料的热稳定性的要求不断提高,因此对具有出色热稳定性和高能量的耐热炸药的研究一直是一项艰巨的挑战。这里,我们提出的合成和先进的耐热炸药双5,5'-(3,5-二硝基- 1的性质ħ吡唑-4-基)-1 ħ,1' ħ -3,3'-双(1,2,4-三唑)(BDBT-2)。该化合物表现出惊人的372°C的热分解温度,8705 ms -1的高爆轰速度,理想的敏感性,并且易于按比例放大。BDBT-2的这些令人印象深刻的特性和充满活力的性能超越了目前和工业上使用的耐热炸药2,2',4,4',6,6'-六硝基sti(HNS)和最近报道的热稳定炸药,有力地支持BDBT-2作为先进的耐热炸药。易爆炸药。此外,区域异构体双5,5'-(3,4-二硝基- 1之间的全面比较ħ -1H-吡唑-5-基)-2- ħ,2' ħ -3,3'-双(1,2,4-三唑)(BDBT-1)和BDBT-2表明,区域
  • Top Development of Green-Light Pyrotechnics: Hypergolic Cu(II)-Based Coordination Polymers
    作者:Ting-wei Wang、Zhen-xin Yi、Lu Zhang、Yi-kai Wang、Yan Li、Jian-guo Zhang
    DOI:10.1021/acs.cgd.2c01176
    日期:2023.1.4
    tests manifested that ECPs-1 had better thermal stability (Tted = 159 °C), while ECPs-2 had a better decomposition rate (ΔT = 25 °C). In addition, their safety was evaluated by measuring their combustion heat and mechanical sensitivity. Using only ECPs-1 and ECPs-2 as the main components of the pyrotechnic agents, the combustion performance and flame color effect were studied. The results proved that
    在结构化学和结晶化学的指导下,通过反应制备了两种配位聚合物Cu(AOCA) 2 (NO 3 ) 2 ( ECPs-1 ) 和[Cu(PZCA)(NO 3 )](NO 3 ) ( ECPs-2 ) 4-amino-1,2,5-oxadiazole-3-carbohydrazide (AOCA) 和pyrazole-4-carbohydrazide (PZCA) 分别与Cu(NO 3 ) 2反应,并对其结构和性质进行了表征。单晶XRD证明ECPs-1为无溶剂零维结构,而ECPs-2为含有配位的一维(1D)结构。TG-DSC 测试表明ECPs-1具有更好的热稳定性 ( T ted = 159 °C),而ECPs-2具有更好的分解速率 (Δ T = 25 °C)。此外,通过测量它们的燃烧热和机械敏感性来评估它们的安全性。仅以ECPs-1和ECPs-2作为烟火剂的主要成分,研究了其燃烧性能和火焰颜
  • Interactions of novel pyrazole ligand and its transition metal complexes with CT-DNA and BSA: A combination of experimental and computational studies
    作者:Nan Zhang、Xiang-rong Liu、Shun-sheng Zhao、Zai-wen Yang
    DOI:10.1016/j.poly.2022.116273
    日期:2023.2
    A novel pyrazole acylhydrazone (C11H11N5O, HL) and its four transition metal complexes [Co(HL)L]NO3(C1), [Ni(HL)L]NO3(C2), [Cu(HL)L]NO3(C3), [Zn(HL)L]NO3(C4) have been synthesized and characterized. The crystal structures of the above five compounds were studied by single-crystal X-ray diffraction analysis. HL was a triclinic crystal system, crystallized in the P-1 space group, and C1-C4 were all six-coordinated
    一种新型吡唑酰腙(C 11 H 11 N 5 O, HL )及其四种过渡属配合物[Co( HL ) L ]NO 3 ( C1 ), [Ni( HL ) L ]NO 3 ( C2 ), [Cu( HL ) L ]NO 3 ( C3 ), [Zn( HL ) L ]NO 3 ( C4 ) 已被合成和表征。通过单晶X射线衍射分析研究了上述五种化合物的晶体结构。HL为三斜晶系,晶系P -1 空间群,C1~C4均为六配位八面体单核结构,两个配体提供NNO供体原子,C 2 / c空间群。HL和C1 - C4与CT-DNA和BSA的动力学相互作用通过紫外-可见吸收光谱、荧光光谱和微量热法测定。此外,使用可用软件通过分子对接模拟计算可能的相互作用。紫外-可见吸收光谱测量表明HL和C1 - C4可以通过嵌入与 CT-DNA 结合。荧光光谱表明HL和C1 - C4可以通过静态机制与BSA结合。微量热研究表明,HL和C1
  • Hirota, Kosaku; Kitade, Yukio; Shimada, Kaoru, Journal of the Chemical Society. Perkin transactions I, 1983, p. 1293 - 1298
    作者:Hirota, Kosaku、Kitade, Yukio、Shimada, Kaoru、Senda, Shiego、Maki, Yoshifumi
    DOI:——
    日期:——
查看更多